6 trends tracked about this subject — the full history, oldest to newest below.
Novartis and Bristol Myers Squibb halt autoimmune CAR-T trials following patient deaths, impacting the sector.
Novartis and Bristol Myers Squibb halt multiple CAR-T clinical trials for autoimmune diseases following patient deaths and safety reviews.
A first-of-its-kind clinical trial demonstrates that CAR T-cell therapy can put severe rheumatoid arthritis into remission.
Recent scientific research explores how human lung immune cells protect against infections and potentially drive autoimmune disease.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A lupus treatment borrowed from cancer therapy is putting patients into remission—with one calling it life-changing.